X-Message-Number: 15595 Date: Sat, 10 Feb 2001 10:47:59 -0800 From: Kennita Watson <> Subject: Drug Decreases Blood Vessel Stiffness in Older Primates January 31, 2001 Proceedings of the National Academy of Sciences/MedscapeWire A new drug that breaks down vascular collagen bonds in the body could be a new treatment for high blood pressure, heart failure, and certain vascular complications of diabetes. The treatment significantly decreased the stiffness of blood vessels in older nonhuman primates, according to a study conducted by scientists from the National Institute on Aging (NIA) and others. ALT-711 (Alteon, Ramsey, New Jersey), a thiazolium-based compound, snips bonds or crosslinks created in the arteries and other tissues when glucose attaches to collagen. Crosslinks are cable-like structures that inhibit the natural flexibility of collagen strands. They tend to proliferate with age. Crosslinks appear to toughen tissues and may cause some of the deterioration associated with aging and diabetes, such as elevated systolic blood pressure, hardened arteries, and impaired kidney function. In the study, 6 rhesus monkeys received doses of ALT-711 every other day for 3 weeks. Six weeks after the last treatment, all of the vessel walls tested were more flexible, and the effect persisted for more than 4 months after final administration of the drug. Blood flow through the heart also increased and this improvement persisted for nearly 10 months after the treatments ended. No significant changes in body weight or routine chemical measurements were detected during the follow-up period. A report on the study was published in the January 30 issue of the Proceedings of the National Academy of Sciences. "Arterial stiffening is a major factor in many of the vascular diseases associated with advancing age," said Edward Lakatta, MD, co-author of the study and chief of the NIA's Laboratory of Cardiovascular Sciences. "The significance of this drug is it alters the properties of the arterial wall and makes it easier for the heart to eject blood into the blood vessels. These results, coupled with prior studies in smaller animals, certainly suggest that ALT-711 may be a safe and efficacious approach to decreasing the impact of arterial stiffness on cardiovascular health. However, further research, including ongoing studies in people, will be needed in order to confirm and extend these findings." Proc Natl Acad Sci USA. 2001;98:1171-1175 -- Live long and prosper, Kennita -- Kennita Watson | I vote Libertarian. | Find out why. http://www.kennita.com | http://www.lp.org/intro Rate This Message: http://www.cryonet.org/cgi-bin/rate.cgi?msg=15595